LUSAKA – Today, February 9, the United States government delivered to Zambia the first shipment of injectable pre-exposure prophylaxis (PrEP) medicine for HIV prevention, making Zambia the second country in the world (after the United States) to offer injectable PrEP outside of a study setting. Injectable PrEP is a safe and effective HIV prevention tool that provides clients with two months of HIV protection between injections. This donation of 14,850 vials of injectable PrEP – called Cabotegravir Long Acting (CAB-LA) – to Zambia’s Ministry of Health will protect 2,000 Zambians…
Read MoreU.S. Government Delivers First Shipment of Injectable PrEP to Zambia
